Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Motexafin
gadolinium may increase the effectiveness of radiation therapy by making tumor cells more
sensitive to treatment.
PURPOSE: Phase I trial to study the effectiveness of radiation therapy plus motexafin
gadolinium in treating patients with bile duct, gallbladder, or pancreatic cancer that cannot
be removed surgically.